| Dr Atiya Iqbal, MD | |
|
7151 Colleyville Blvd, Suite 103, Colleyville, TX 76034-8029 | |
| (817) 416-1931 | |
| (817) 488-8527 |
| Full Name | Dr Atiya Iqbal |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 34 Years |
| Location | 7151 Colleyville Blvd, Colleyville, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013052570 | NPI | - | NPPES |
| 8AD148 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | N0121 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Patient First Medical Group Pa | 4385709914 | 2 |
News Archive
Eli Lilly and Company today announced positive top-line results of two additional Phase III AWARD trials for dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a once-weekly treatment for type 2 diabetes.
IBM Watson Health today published its 50 Top Cardiovascular Hospitals annual study identifying top U.S. hospitals for inpatient cardiovascular services based on a balanced national scorecard of hospital performance metrics.
Colonies of hospital superbugs can make poisons similar to those found in rattlesnake venom to attack our bodies' natural defences, scientists heard today (Monday 8 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.
MSD reported that final results from a Phase III study of 'Victrelis', its investigational oral hepatitis C protease inhibitor, added to peginterferon alfa-2a marketed by Roche Products Limited, and ribavirin therapy were presented for the first time today as part of a late-breaker poster session at The International Liver Congress / 46th European Association for the Study of the Liver annual meeting.
Medicare's actuary warned Tuesday that controlling cost growth is the primary challenge to the entitlement program's financial stability, but that neither the premium support system sought by Republicans nor cost-cutting measures pushed by the administration provide all the answers.
› Verified 2 days ago
| Entity Name | Patient First Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528206612 PECOS PAC ID: 4385709914 Enrollment ID: O20090216000362 |
News Archive
Eli Lilly and Company today announced positive top-line results of two additional Phase III AWARD trials for dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a once-weekly treatment for type 2 diabetes.
IBM Watson Health today published its 50 Top Cardiovascular Hospitals annual study identifying top U.S. hospitals for inpatient cardiovascular services based on a balanced national scorecard of hospital performance metrics.
Colonies of hospital superbugs can make poisons similar to those found in rattlesnake venom to attack our bodies' natural defences, scientists heard today (Monday 8 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.
MSD reported that final results from a Phase III study of 'Victrelis', its investigational oral hepatitis C protease inhibitor, added to peginterferon alfa-2a marketed by Roche Products Limited, and ribavirin therapy were presented for the first time today as part of a late-breaker poster session at The International Liver Congress / 46th European Association for the Study of the Liver annual meeting.
Medicare's actuary warned Tuesday that controlling cost growth is the primary challenge to the entitlement program's financial stability, but that neither the premium support system sought by Republicans nor cost-cutting measures pushed by the administration provide all the answers.
› Verified 2 days ago
| Entity Name | Colleyville Md Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851760979 PECOS PAC ID: 1759684681 Enrollment ID: O20160126002331 |
News Archive
Eli Lilly and Company today announced positive top-line results of two additional Phase III AWARD trials for dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a once-weekly treatment for type 2 diabetes.
IBM Watson Health today published its 50 Top Cardiovascular Hospitals annual study identifying top U.S. hospitals for inpatient cardiovascular services based on a balanced national scorecard of hospital performance metrics.
Colonies of hospital superbugs can make poisons similar to those found in rattlesnake venom to attack our bodies' natural defences, scientists heard today (Monday 8 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.
MSD reported that final results from a Phase III study of 'Victrelis', its investigational oral hepatitis C protease inhibitor, added to peginterferon alfa-2a marketed by Roche Products Limited, and ribavirin therapy were presented for the first time today as part of a late-breaker poster session at The International Liver Congress / 46th European Association for the Study of the Liver annual meeting.
Medicare's actuary warned Tuesday that controlling cost growth is the primary challenge to the entitlement program's financial stability, but that neither the premium support system sought by Republicans nor cost-cutting measures pushed by the administration provide all the answers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Atiya Iqbal, MD Po Box 96221, Southlake, TX 76092-0127 Ph: (817) 424-3366 | Dr Atiya Iqbal, MD 7151 Colleyville Blvd, Suite 103, Colleyville, TX 76034-8029 Ph: (817) 416-1931 |
News Archive
Eli Lilly and Company today announced positive top-line results of two additional Phase III AWARD trials for dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a once-weekly treatment for type 2 diabetes.
IBM Watson Health today published its 50 Top Cardiovascular Hospitals annual study identifying top U.S. hospitals for inpatient cardiovascular services based on a balanced national scorecard of hospital performance metrics.
Colonies of hospital superbugs can make poisons similar to those found in rattlesnake venom to attack our bodies' natural defences, scientists heard today (Monday 8 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.
MSD reported that final results from a Phase III study of 'Victrelis', its investigational oral hepatitis C protease inhibitor, added to peginterferon alfa-2a marketed by Roche Products Limited, and ribavirin therapy were presented for the first time today as part of a late-breaker poster session at The International Liver Congress / 46th European Association for the Study of the Liver annual meeting.
Medicare's actuary warned Tuesday that controlling cost growth is the primary challenge to the entitlement program's financial stability, but that neither the premium support system sought by Republicans nor cost-cutting measures pushed by the administration provide all the answers.
› Verified 2 days ago
Dr. Mohammad N Uddin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7151 Colleyville Blvd, Suite 103, Colleyville, TX 76034 Phone: 817-416-1931 Fax: 817-488-8527 | |
Dr. Roger Guthrie, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 W Murphy Rd, Colleyville, TX 76034 Phone: 817-514-8391 | |
Melinda Denise Harrell, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5207 Heritage Ave, Colleyville, TX 76034 Phone: 817-355-8000 | |
Kathryn S Byrd, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5232 Colleyville Blvd, Ste 100, Colleyville, TX 76034 Phone: 817-912-9920 Fax: 817-912-9911 | |
Dr. Margaret H Walter, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 5408 Colleyville Blvd, Colleyville, TX 76034 Phone: 817-498-9920 Fax: 817-498-0635 | |
Dr. Song Young Lee, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 6220 Colleyville Blvd, Suite B, Colleyville, TX 76034 Phone: 817-416-0525 Fax: 817-416-5831 |